The incidence of early-onset cancers is not rising overall, but rates of certain cancers are increasing among younger patients, new data suggest.

LIKE most of us, when Zee Valentina began feeling more tired than normal, she – and even her doctors – dismissed it as ...

(NASDAQ: ONC; HKEX: 06160; SSE: 688235), a global oncology company that will change its name to BeOne Medicines Ltd., today announced it will share data across a range of hematologic malignancies at ...

such as a non-healing sore or area of rough skin. To find out what this skin cancer can look like and see pictures of it, go to: Squamous cell carcinoma of the skin: Signs and symptoms. Anadolu-Brasie ...

JOE THOMPSON’S tearful widow paid tribute to “my soulmate, my everything” at the ex-Manchester United starlet’s funeral. The ...

A next-generation "armored" CAR T cell therapy showed promising results in a small study of patients whose B-cell lymphomas ... Another trial for non-Hodgkin's lymphoma using a similar IL18 ...

The main illness examined was cases of non-Hodgkin lymphoma, a cancer known as NHL that starts in white blood cells and can affect the immune system. Read Next: 48 Hours with Marines and Soldiers ...

Zevaskyn is applied as genetically engineered skin grafts to treat chronic wounds in RDEB patients ... approval for Zevaskyn (prademagene zamikeracel), a gene-corrected cell therapy designed to treat ...

Hodgkin lymphoma and ... Recently, CAR-T cell therapies have emerged as a promising alternative for treating haematological malignancies, achieving very positive results in B-cell leukaemias ...

Zevaskyn, chemically known as pz-cel, works by adding healthy COL7A1 genes to patient's skin cells and transplanting them back to the patient through a skin graft to heal the large and chronic wounds.

The abstract by Zucca et al, entitled, “Observation vs. radiotherapy in primary mediastinal B-cell lymphoma patients with complete response to standard immunochemotherapy: The IELSG37 randomized trial ...